Alector, Inc. (ALEC) income statement
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.33+0.04 (+1.52%)
Close on Nov 20, 2026Market cap $260.72MP/E –Yield –
Alector, Inc. financial ratios
See a number that looks wrong?